MORANO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 267
AS - Asia 234
EU - Europa 203
SA - Sud America 18
OC - Oceania 3
AF - Africa 2
Totale 727
Nazione #
US - Stati Uniti d'America 262
SG - Singapore 101
RU - Federazione Russa 95
CN - Cina 63
IT - Italia 47
HK - Hong Kong 24
KR - Corea 19
BR - Brasile 15
IE - Irlanda 15
FI - Finlandia 12
DE - Germania 9
JO - Giordania 8
CH - Svizzera 7
IN - India 7
SE - Svezia 7
VN - Vietnam 5
CA - Canada 4
AU - Australia 3
GB - Regno Unito 3
ES - Italia 2
JP - Giappone 2
TH - Thailandia 2
UA - Ucraina 2
AR - Argentina 1
CL - Cile 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
FR - Francia 1
ID - Indonesia 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
PE - Perù 1
PL - Polonia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 727
Città #
Santa Clara 117
Singapore 90
Hefei 29
Ashburn 26
Hong Kong 22
Seoul 19
Dublin 15
Chandler 12
Florence 9
Arezzo 8
Turku 8
Beijing 7
Bern 7
Rome 7
Buffalo 6
Los Angeles 5
Helsinki 4
Lawrence 4
Modena 4
Munich 4
New York 4
Shanghai 4
Wilmington 4
Cambridge 3
Fairfield 3
Frankfurt am Main 3
Houston 3
Melbourne 3
Mississauga 3
Mumbai 3
Yubileyny 3
Altamura 2
Atlanta 2
Boardman 2
Bologna 2
Boston 2
Can Tho 2
Chengdu 2
Düsseldorf 2
Ho Chi Minh City 2
Kent 2
Lurate Caccivio 2
Moscow 2
Prad am Stilfser Joch 2
Princeton 2
Seattle 2
São Paulo 2
Tokyo 2
Udine 2
Vicopisano 2
Ankara 1
Ann Arbor 1
Bagno a Ripoli 1
Bangkok 1
Bengaluru 1
Betim 1
Bhiwāni 1
Bismarck 1
Boise 1
Brno 1
Brooklyn 1
Cajamar 1
Cardiff 1
Castel San Giovanni 1
Ceres 1
Chennai 1
Chicago 1
Djibouti 1
Formosa 1
Goiânia 1
Hanoi 1
Hillsboro 1
Jaboatão dos Guararapes 1
Jakarta 1
Kyiv 1
Lima region 1
Limeira 1
London 1
Long Beach 1
Manaus 1
Miami 1
Midland 1
Milan 1
Newark 1
North Bergen 1
Norwalk 1
Osasco 1
Paris 1
Penápolis 1
Phoenix 1
Porto Alegre 1
Pune 1
Querétaro 1
Rabat 1
Redondo Beach 1
San Diego 1
San Marco dei Cavoti 1
Saronno 1
Sorocaba 1
São Luís 1
Totale 527
Nome #
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 191
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: The Colon Life nomogram 167
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 145
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial 121
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer 114
Totale 738
Categoria #
all - tutte 2.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 1 1 2 1 1
2021/202213 1 0 1 1 0 0 0 2 0 0 3 5
2022/2023101 2 11 0 4 3 14 10 22 15 0 11 9
2023/202460 0 4 5 5 5 7 1 14 1 10 1 7
2024/2025305 12 32 15 46 89 48 8 6 8 14 15 12
2025/2026244 32 45 39 37 87 4 0 0 0 0 0 0
Totale 738